Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer

Mike Atkins describes the results of this study which helps shed light on the role of ipilimumab and nivolumab in this disease. 

2356 232

Suggested Podcasts

Tobi Johnson a Jennifer Bennett: Volunteer management experts

Charlie Ambler

Adam Crisafulli

Prarthana Khare

Akash Narula